Illumina Reagents and Consumables

The National Heart, Lung, and Blood Institute (NHLBI), a division of the Department of Health and Human Services, is preparing to issue a sole-source contract for Illumina reagents and consumables specifically compatible with their 201 Illumina sequencing and genotyping systems. The procurement will include a comprehensive range of laboratory materials such as Library Preparation Kits, Enrichment Kits, Sequencing Kits, Custom and Standard Oligo Pools, Reagent Kits, Arrays, Flow Cells, and related accessories. Potential contractors must demonstrate technical capabilities to support high-performance sequencing requirements, including the ability to produce up to 300 Mb on small scale sequencers and up to 16,000 Gb on high-throughput sequencers per run. The government has classified this opportunity under NAICS code 334516 for Analytical Laboratory Instrument Manufacturing, with a size standard of 1,000 employees. Interested parties must submit capability statements by January 6, 2025, at 12:00pm ET through SAM.gov and via email to the designated contracting officer.

The contract will be a sole-source award to Illumina, Inc., justified by their status as the exclusive manufacturer of compatible reagents and consumables for their proprietary sequencing systems, with no authorized third-party resellers. The period of performance is scheduled from September 3, 2025, to September 2, 2030, representing a five-year contract term. While specific award values are not disclosed in the pre-solicitation notice, the comprehensive nature of the procurement suggests a potentially significant contract scope. The technical requirements emphasize versatility, supporting multiple scientific applications including RNA-Seq and whole genome sequencing, with particular capabilities for working with low input sample volumes. The solicitation signals NHLBI's commitment to maintaining advanced genomic research capabilities through specialized, manufacturer-specific laboratory consumables.